Invention Application
- Patent Title: APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Application No.: US14994824Application Date: 2016-01-13
-
Publication No.: US20160206611A1Publication Date: 2016-07-21
- Inventor: Le Wang , George Doherty , Xilu Wang , Zhi-Fu Tao , Milan Bruncko , Aaron R. Kunzer , Michael D. Wendt , Xiaohong Song , Robin Frey , Todd M. Hansen , Gerard M. Sullivan , Andrew Judd , Andrew Souers
- Applicant: AbbVie Inc.
- Main IPC: A61K31/4725
- IPC: A61K31/4725 ; A61K31/5377 ; C07D417/14
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Public/Granted literature
- US09877958B2 Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases Public/Granted day:2018-01-30
Information query
IPC分类:
